Aerie Pharmaceuticals reported $-34219000 in EBIT for its first fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Adamas Pharmaceuticals ADMS:US -9525000 5.45M
Aerie Pharmaceuticals AERI:US $ -34219000 1.37M
Alimera Sciences ALIM:US $ -2235000 2.41M
Amarin AMRN:US -1331000 8.49M
Antares Pharma ATRS:US $ 5.39M 707K
Bluebird Bio BLUE:US $ -230839000 25.98M
Cara Therapeutics CARA:US $ -23561000 101.85M
Endo International Ordinary Shares ENDP:US $ 219.43M 43.78M
Flexion Therapeutics FLXN:US $ -23141000 8.84M
Gw Pharmaceuticals GWPH:US -21027000 1.78M
Horizon Pharma HZNP:US -89446000 326.97M
Insmed INSM:US $ -83833000 10.7M
JAZZ PHA JAZZ:US 162.12M 11.3M
Merk MRK:US $ 4290M 4007M
Mirati Therapeutics MRTX:US $ -132421000 26.09M
Novartis NOVN:VX 2.99B 332M
Pacira Pharmaceuticals PCRX:US $ 21.31M 4.24M
Regeneron Pharmaceuticals REGN:US $ 1112.7M 54.3M
Revance Therapeutics RVNC:US $ -70012000 7.96M
Supernus Pharmaceuticals SUPN:US $ 13.21M 29.88M
Teva Pharmaceutical Industries TEVA:US 794M 12M
Valeant Pharmaceuticals VRX:CN C$ 378M 52M
Zoetis ZTS:US $ 759M 243M